|
Orthologous residues
|
|
TAX1BP1 (human): S593‑p, TAX1BP1 iso2 (human): S593‑p, TAX1BP1 (mouse): S619‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mass spectrometry, mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial), macrophage-bone marrow, MEF (fibroblast)
|
|
Cellular systems studied:
cell lines, primary cultured cells
|
|
Species studied:
human, mouse
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
IKK-alpha (human)
|
modification site within consensus motif, siRNA inhibition of enzyme, transfection of wild-type enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
TNF
|
|
|
|
increase
|
|
|
IL-1a
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation, ubiquitination
|
|
Effect of modification (process):
signaling pathway regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
TRAF2 (human)
|
|
Induces
|
|
|
co-immunoprecipitation
|
|
TRAF6 (human)
|
|
Induces
|
|
|
co-immunoprecipitation
|
|
|
Comments:
regulates NF-kB signaling; regulates interaction with A20 and Itch via TRAF2 and TRAF6;
|